Achyut Healthcare Limited
BSE: ACHYUT
BSE
5.93
-0.12 (-1.98%)
Prev Close
6.05
Open Price
5.93
Volume
31,500
Today Low / High
5.93 / 5.93
52 WK Low / High
2.82 / 6.57
Range
6 - 6
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 5.93, reflecting a change of -0.12 (-1.98347%). The expected target range on the BSE is 6 - 6. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
16 Oct
5.93
0.00%
08 Oct
6.05
0.00%
Achyut Healthcare Limited Graph
Achyut Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Achyut Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 5.93, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 5.93 | 5.99 | 5.39 - 6.59 |
| 6.05 | 4.84 - 7.26 | ||
| 6.11 | 4.28 - 7.94 | ||
| Bearish Scenario | 5.93 | 5.87 | 5.28 - 6.46 |
| 5.81 | 4.65 - 6.97 | ||
| 5.75 | 4.03 - 7.48 |
Overview of Achyut Healthcare Limited
ISIN
INE0K1401012
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
409,500
Market Cap
1,396,853,010
Last Dividend
0
Official Website
IPO Date
DCF Diff
65.68
DCF
-18
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 3.05 Cr | 2.87 Cr | 0.18 Cr | 0.0577 | 0.00 Cr | 0.00 Cr | -0.22 Cr | 0.55 Cr | 0.33 | 0.72 Cr | 0.1797 |
| 2024-03-31 | 6.14 Cr | 5.53 Cr | 0.60 Cr | 0.0985 | 0.00 Cr | 0.00 Cr | 0.44 Cr | 0.57 Cr | 0.41 | 0.05 Cr | 0.0934 |
| 2023-03-31 | 2.54 Cr | 2.03 Cr | 0.51 Cr | 0.1998 | 0.00 Cr | 0.00 Cr | -0.28 Cr | 0.23 Cr | 0.16 | -0.26 Cr | 0.0909 |
| 2022-03-31 | 3.58 Cr | 3.37 Cr | 0.21 Cr | 0.0586 | 0.00 Cr | 0.00 Cr | -0.04 Cr | 0.04 Cr | 0.04 | -0.03 Cr | 0.0113 |
| 2021-03-31 | 0.27 Cr | 0.24 Cr | 0.04 Cr | 0.1291 | 0.00 Cr | 0.00 Cr | 0.01 Cr | 0.01 Cr | 0.01 | 0.01 Cr | 0.0271 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.00 Cr | 32.59 Cr | 1.29 Cr | 31.2986 Cr | 0.00 Cr | -1.00 Cr | 0.19 Cr | 18.22 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 1.2936 Cr |
| 2024-03-31 | 0.37 Cr | 30.95 Cr | 0.20 Cr | 30.7509 Cr | 0.00 Cr | -0.37 Cr | 0.06 Cr | 9.22 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.2014 Cr |
| 2023-03-31 | 0.23 Cr | 15.34 Cr | 0.82 Cr | 14.5238 Cr | 0.00 Cr | -0.23 Cr | 0.45 Cr | 3.54 Cr | 0.31 Cr | 0.00 Cr | 1.30 Cr | 0.8167 Cr |
| 2022-03-31 | 0.26 Cr | 9.94 Cr | 0.86 Cr | 9.0846 Cr | 0.00 Cr | -0.26 Cr | 0.13 Cr | 0.03 Cr | 0.47 Cr | 0.00 Cr | 1.70 Cr | 0.8566 Cr |
| 2021-03-31 | 0.02 Cr | 0.47 Cr | 0.25 Cr | 0.2170 Cr | 0.00 Cr | -0.02 Cr | 0.10 Cr | 0.00 Cr | 0.01 Cr | 0.00 Cr | 0.00 Cr | 0.2543 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -4.0641 Cr | 4.6866 Cr | 0.0000 Cr | -14.9288 Cr | 0.6225 Cr | 0.9971 Cr | -10.8647 Cr | 0.7035 Cr | 0.0000 Cr | 0.0000 Cr | -0.1293 Cr |
| 2024-03-31 | -0.3581 Cr | -15.2263 Cr | 15.7248 Cr | -6.3698 Cr | 0.1404 Cr | 0.3746 Cr | -6.0117 Cr | 0.5732 Cr | 0.0000 Cr | 0.0000 Cr | 0.2601 Cr |
| 2023-03-31 | 0.1513 Cr | -5.3865 Cr | 5.2080 Cr | -3.1685 Cr | -0.0272 Cr | 0.2342 Cr | -3.3198 Cr | 0.2312 Cr | 0.0000 Cr | 0.0000 Cr | -0.1900 Cr |
| 2022-03-31 | -6.8172 Cr | -1.7373 Cr | 8.7941 Cr | -6.8497 Cr | 0.2397 Cr | 0.2614 Cr | -0.0325 Cr | 0.0403 Cr | 0.0000 Cr | 0.0000 Cr | -0.0310 Cr |
| 2021-03-31 | 0.0093 Cr | 0.0002 Cr | 0.0000 Cr | 0.0093 Cr | 0.0093 Cr | 0.0217 Cr | 0.0000 Cr | 0.0074 Cr | 0.0000 Cr | 0.0000 Cr | -0.0959 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.92 Cr | 0.89 Cr | 0.03 Cr | 0.0376 | -0.13 Cr | 0.20 Cr | 0.12 | 0.24 Cr | 0.2117 |
| 2024-09-30 | 2.13 Cr | 2.14 Cr | -0.02 Cr | -0.0074 | -0.09 Cr | 0.35 Cr | 0.21 | 0.48 Cr | 0.1659 |
| 2024-03-31 | 4.65 Cr | 4.49 Cr | 0.16 Cr | 0.0348 | -0.01 Cr | 0.31 Cr | 0.22 | 0.01 Cr | 0.0671 |
| 2023-09-30 | 1.48 Cr | 1.16 Cr | 0.32 Cr | 0.2185 | 0.03 Cr | 0.26 Cr | 0.19 | 0.02 Cr | 0.1759 |
| 2023-03-31 | 0.81 Cr | 0.59 Cr | 0.22 Cr | 0.2672 | -0.29 Cr | -0.01 Cr | -0.01 | 0.07 Cr | -0.0114 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.00 Cr | 0.00 Cr | 1.00 Cr | 10.87 Cr | 0.19 Cr | 12.06 Cr | 18.22 Cr | 32.59 Cr | 1.29 Cr |
| 2024-09-30 | 0.83 Cr | 0.00 Cr | 0.83 Cr | 0.90 Cr | 0.06 Cr | 16.02 Cr | 14.02 Cr | 31.93 Cr | 0.83 Cr |
| 2024-03-31 | 0.37 Cr | 20.52 Cr | 20.89 Cr | 0.42 Cr | 0.06 Cr | 21.47 Cr | 9.22 Cr | 30.95 Cr | 0.20 Cr |
| 2023-09-30 | 0.13 Cr | 0.00 Cr | 0.13 Cr | 7.31 Cr | 0.12 Cr | 7.57 Cr | 7.09 Cr | 15.13 Cr | 0.35 Cr |
| 2023-03-31 | 0.23 Cr | 8.46 Cr | 8.69 Cr | 1.15 Cr | 0.45 Cr | 10.35 Cr | 3.54 Cr | 15.34 Cr | 0.82 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.20 Cr | -1.64 Cr | 1.80 Cr | 0.00 Cr | 0.00 Cr | 1.00 Cr | 0.83 Cr | -4.93 Cr | -6.57 Cr |
| 2024-09-30 | 0.35 Cr | -1.52 Cr | 1.98 Cr | 0.00 Cr | 0.46 Cr | 0.83 Cr | 0.37 Cr | -5.93 Cr | -7.46 Cr |
| 2024-03-31 | 0.31 Cr | -0.47 Cr | -15.01 Cr | 15.72 Cr | 0.24 Cr | 0.37 Cr | 0.13 Cr | -2.13 Cr | -2.60 Cr |
| 2023-09-30 | 0.26 Cr | 0.41 Cr | -0.51 Cr | 0.00 Cr | -0.10 Cr | 0.13 Cr | 0.23 Cr | -3.88 Cr | -3.48 Cr |
| 2023-03-31 | -0.01 Cr | -0.79 Cr | -5.21 Cr | 5.21 Cr | -0.40 Cr | -0.40 Cr | 0.00 Cr | -3.32 Cr | -4.11 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2024-12-10 | December 10, 24 | 10:1 |
| 2023-05-03 | May 03, 23 | 3:2 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,687.00 | ₹4,047,671,982,389.00 | ₹2,440,907.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,438.50 | ₹1,709,224,809,162.00 | ₹305,872.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,576.50 | ₹1,210,448,542,500.00 | ₹133,893.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,289.40 | ₹1,073,250,238,305.00 | ₹1,828,269.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹1,001.25 | ₹1,007,487,347,951.00 | ₹382,044.00 |
| Mankind Pharma Limited | MANKIND | ₹2,406.50 | ₹993,303,306,185.00 | ₹271,023.00 |
| Lupin Limited | LUPIN | ₹1,918.70 | ₹876,381,321,332.00 | ₹668,996.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,432.00 | ₹649,477,080,000.00 | ₹156,752.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,099.40 | ₹638,533,304,326.00 | ₹1,130,406.00 |
| Laurus Labs Limited | LAURUSLABS | ₹959.65 | ₹518,042,964,325.00 | ₹2,714,923.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,815.10 | ₹512,222,688,416.00 | ₹339,123.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Cohance Lifesciences Limited | COHANCE | ₹859.70 | ₹328,892,970,258.00 | ₹338,239.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,285.90 | ₹326,238,253,926.00 | ₹63,010.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,388.40 | ₹298,396,244,362.00 | ₹56,805.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,686.00 | ₹264,021,258,954.00 | ₹36,351.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Emcure Pharmaceuticals L | EMCURE | ₹1,326.00 | ₹251,362,987,122.00 | ₹89,776.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,315.50 | ₹232,887,500,000.00 | ₹17,491.00 |
| Eris Lifesciences Limited | ERIS | ₹1,628.40 | ₹221,810,151,334.00 | ₹201,101.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,296.90 | ₹210,726,538,417.00 | ₹240,869.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹15,740.00 | ₹201,942,452,860.00 | ₹26,058.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹905.60 | ₹178,007,565,094.00 | ₹64,648.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,122.00 | ₹177,893,979,648.00 | ₹220,240.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,012.00 | ₹152,935,532,352.00 | ₹30,388.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹826.50 | ₹148,034,307,555.00 | ₹240,008.00 |
| Granules India Limited | GRANULES | ₹569.95 | ₹138,309,034,684.00 | ₹457,943.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Alivus Life Sciences Limited | ALIVUS | ₹905.95 | ₹111,143,167,221.00 | ₹89,266.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,183.00 | ₹102,633,978,906.00 | ₹5,459.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹843.00 | ₹76,403,592,867.00 | ₹103,602.00 |
| Strides Pharma Science Limited | STAR | ₹814.00 | ₹75,028,589,196.00 | ₹168,130.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹361.10 | ₹70,624,593,758.00 | ₹144,078.00 |
| FDC Limited | FDC | ₹432.05 | ₹70,342,096,792.00 | ₹151,149.00 |
| Akums Drugs And Pharma L | AKUMS | ₹457.20 | ₹69,998,260,918.00 | ₹100,352.00 |
| Sequent Scientific Limited | SEQUENT | ₹206.17 | ₹51,524,532,078.00 | ₹1,087,872.00 |
| Gujarat Themis Biosyn Limited | GUJTHEM | ₹460.00 | ₹50,124,021,900.00 | ₹1,023,719.00 |
| Innova Captab Limited | INNOVACAP | ₹809.85 | ₹46,343,608,751.00 | ₹13,089.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹142.23 | ₹46,156,705,461.00 | ₹7,842,918.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹481.10 | ₹43,909,997,000.00 | ₹215,251.00 |
| Suven Life Sciences Limited | SUVEN | ₹194.00 | ₹42,299,895,218.00 | ₹85,389.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,377.50 | ₹39,321,508,163.00 | ₹8,656.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹703.85 | ₹35,698,642,054.00 | ₹75,131.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹337.35 | ₹33,830,303,399.00 | ₹45,042.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹465.55 | ₹32,777,396,913.00 | ₹10,150.00 |
Key Executives
Executive Officer
Mr. Piyush Jagdishbhai Madhwan
Gender: male
Year Born: 1990
Executive Officer
Trupti B. Kacha
Gender: Not Specified
Year Born: 1978
Executive Officer
Deepak Natvarlal Rana
Gender: Not Specified
Year Born:
Executive Director
Ms. Amisha Jigen Modi
Gender: female
Year Born: 1970
Executive Officer
Mr. Mevada Premchandabhai
Gender: male
Year Born: 1980
Executive Officer
Vikram B. Thakor
Gender: Not Specified
Year Born: 1977
Executive Officer
Mr. Pravinbhai Somabhai Shrimal
Gender: male
Year Born: 1972
MD, Chief Financial Officer & Executive Director
Mr. Jigen Jagdishbhai Modi
Gender: male
Year Born: 1969
FAQs about Achyut Healthcare Limited
Who is the CEO of the company?
The CEO is Jigen Jagdishbhai Modi.
What is the current market price of the stock?
The current price is ₹5.93.
What is the 52-week price range?
The range is ₹2.82-6.57.
What is the market capitalization of the company?
The market capitalization is ₹139.69 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 18.22.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Achyut Healthcare Limited (ISIN: INE0K1401012) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹139.69 crores and an average daily volume of 409,500 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.